Clinical Trials

Psychosocial Protocols in Psychedelic Therapy: A Scoping Review

New review highlights need for standardized protocols in psychedelic-assisted therapy to enhance transparency and evaluation.

Published June 26, 2026 Read 1 min 327 words By The Psychedelic Journal

Standardizing Psychosocial Protocols in Psychedelic Therapy

A recent scoping review highlights the critical need for standardized psychosocial protocols in psychedelic-assisted therapy to enhance transparency and evaluation. As psychedelic substances gain traction in treating mental health disorders, the accompanying psychosocial interventions are essential for understanding treatment outcomes. This review categorizes existing protocols, underscoring the necessity of a shared language to facilitate consistent reporting and evaluation across studies.

Mechanisms and Context of Psychosocial Protocols

Psychosocial protocols in psychedelic therapy encompass various elements, including therapeutic orientation, duration, and cultural context. The review identified 62 eligible studies using substances such as Ayahuasca, Psilocybin, and MDMA, revealing seven categories of protocols. These categories reflect different emphases on the substance, participant, research team, and sociocultural context, highlighting the diversity in research intentions and contextual constraints. By defining these parameters, researchers can better compare and examine protocols, reducing conceptual uncertainty in the field.

Implications for Policy and Research

The development of standardized psychosocial protocols has significant implications for both policy and research in psychedelic therapy. Clear definitions and structured study designs can facilitate research decision-making and support the creation of replicable studies. This structured approach is crucial for developing culturally responsive and population-specific care, ensuring that psychedelic therapy advances responsibly and ethically.

Risks and Unknowns in Current Protocols

Despite the progress outlined in the review, several risks and unknowns remain. Limited reporting and heterogeneity in existing studies present methodological challenges, and the diverse research intentions reflect varying contextual constraints. These issues underscore the need for balance between methodological rigor and real-world applicability, as well as the importance of interdisciplinary perspectives and demographic diversity in future research.

Future Directions in Psychedelic Research

Looking forward, the explicit definition of psychosocial protocols' intended purposes will likely enhance their transparent reporting and evaluation. Future research should strive to balance methodological rigor with attention to real-world studies, interdisciplinary perspectives, and demographic diversity. By doing so, the field can advance responsibly, ensuring that psychedelic therapy remains both effective and ethical.

Primary source: https://openalex.org/W7166328922 — referenced for fact-checking; this analysis is independent commentary by the The Psychedelic Journal editorial team.
Found this useful?

Get tomorrow's briefing in your inbox

Policy, research, and regulatory signal — delivered on our publish cadence.

Free. No spam. Unsubscribe anytime.